About the Authors
- Luis F. López-Cortés
-
* E-mail: lflopez@us.es
Affiliation Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain
- Manuel A. Castaño
-
Affiliation Hospital Universitario Carlos Haya, Málaga, Spain
- Miguel A. López-Ruz
-
Affiliation Hospital Universitario Virgen de las Nieves, Granada, Spain
- María J. Rios-Villegas
-
Affiliation Hospital Universitario Virgen Macarena, Sevilla, Spain
- José Hernández-Quero
-
Affiliation Hospital Universitario San Cecilio, Granada, Spain
- Dolores Merino
-
Affiliation Complejo Hospitalario Juan Ramón Jiménez, Huelva, Spain
- Patricia Jiménez-Aguilar
-
Affiliation Hospital Universitario de Puerto Real, Cádiz, Spain
- Manuel Marquez-Solero
-
Affiliation Hospital Universitario Virgen de la Victoria, Málaga, Spain
- Alberto Terrón-Pernía
-
Affiliation Hospital Jerez de la Frontera, Cádiz, Spain
- Francisco Tellez-Pérez
-
Affiliation Hospital La Línea, Cádiz, Spain
- Pompeyo Viciana
-
Affiliation Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain
- Francisco Orihuela-Cañadas
-
Affiliation Hospital Universitario Carlos Haya, Málaga, Spain
- Zaira Palacios-Baena
-
Affiliation Hospital Universitario Virgen Macarena, Sevilla, Spain
- David Vinuesa-Garcia
-
Affiliation Hospital Universitario San Cecilio, Granada, Spain
- Jose M. Fajardo-Pico
-
Affiliation Complejo Hospitalario Juan Ramón Jiménez, Huelva, Spain
- Alberto Romero-Palacios
-
Affiliation Hospital Universitario de Puerto Real, Cádiz, Spain
- Guillermo Ojeda-Burgos
-
Affiliation Hospital Universitario Virgen de la Victoria, Málaga, Spain
- Juan Pasquau-Liaño
-
Affiliation Hospital Universitario Virgen de las Nieves, Granada, Spain
Competing Interests
FL and PV have received unrestricted grants for research and personal fees for speaking at symposia on behalf of Abbvie laboratories (Spain), Bristol-Myers Squibb, Glaxo Smithkline, Gilead Sciences, Janssen España, Merck Sharp & Dohme España, Roche Pharma SA, and ViiV Healthcare. MAL and MM have received unrestricted research grants and personal fees for speaking at symposia on behalf of Abbott laboratories (Spain), Janssen España, Merck Sharp & Dohme España, and ViiV Healthcare. JP has received unrestricted grants for research and speaker honoraria from Bristol-Myers Squibb, Janssen, Abbvie laboratories, Merck Sharp & Dohme, ViiV Healthcare, Gilead Sciences and Roche Pharma. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All other authors have no competing interests to declare.
Author Contributions
Conceived and designed the experiments: LFL. Performed the experiments: LFL MAC MAL MJR JH DM PJ MM AT FT PV FO ZP DV JMF AR GO JP. Analyzed the data: LFL. Contributed reagents/materials/analysis tools: LFL MAC MAL MJR JH DM PJ MM AT FT PV FO ZP DV JMF AR GO JP. Wrote the paper: LFL. Critical revision of the article for important intellectual content: JH DM JP.